SoBran has signed a multi-year contract to provide managerial and supervisory personnel for the University of Texas Southwestern Medical Center in Dallas, TX. Under this contract SoBran will
OrbusNeich’s interim data from a prospective registry showed good safety in a broad population of patients that underwent primary percutaneous coronary intervention (PCI) and implantation of the company’s
AIDS Healthcare Foundation (AHF) has disclosed its plans to open its first AIDS treatment center in Washington, DC, on September 24, 2009. AHF’s health care center, to be
QIAGEN has acquired DxS, a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, UK. The transaction is valued at approximately $95m in cash, plus up
BioTime, has revealed its plan to organize a new subsidiary, BioTime Asia, for the purpose of clinically developing and marketing therapeutic stem cell products in the People’s Republic
Amgen has detailed its results from a phase 3, head-to-head trial evaluating denosumab versus Zometa in the treatment of bone metastases. The trial was conducted in 2,046 patients
Nycomed will invest in a state-of-the-art pharmaceutical production plant near the city of Yaroslavl in Russia. The company plans to invest between E65m to E75m. The company said
Karnataka drug controller, Dr BR Jagashetty has asked to amend Drugs & Cosmetics Act to restrict the movement of not-of-standard quality and defective packaging drugs in the state.
Lundbeck, a wholly owned subsidiary of H Lundbeck in Denmark, has announced that Sabril (vigabatrin) tablets and powder for Oral Solution are now available for prescribing in the
AEterna Zentaris has announced the completion of a phase 1 study of orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.